New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease

Darla R Shores, David G. Binion, Bruce A. Freeman, Paul R S Baker

Research output: Contribution to journalArticle

Abstract

Dietary and endogenously modified lipids modulate inflammation by functioning as intra- and intercellular signaling molecules. Proinflammatory lipid mediators such as the eicosanoids compete against the signaling actions of newly discovered modified fatty acids that act to resolve inflammation. In inflammatory bowel disease, multiple aberrancies in lipid metabolism have been discovered, which shed further light on the pathogenesis of intestinal inflammation. Mechanisms by which lipids modulate inflammation, abnormalities of lipid metabolism in the setting of inflammatory bowel disease, and potential therapeutic application of lipid derivatives in this setting are discussed. (Inflamm Bowel Dis 2010)

Original languageEnglish (US)
Pages (from-to)2192-2204
Number of pages13
JournalInflammatory Bowel Diseases
Volume17
Issue number10
DOIs
StatePublished - Oct 2011
Externally publishedYes

Fingerprint

Inflammatory Bowel Diseases
Fatty Acids
Inflammation
Lipids
Lipid Metabolism
Eicosanoids
Therapeutics

Keywords

  • fatty acids
  • inflammation
  • inflammatory bowel disease
  • metabolism
  • therapy

ASJC Scopus subject areas

  • Gastroenterology
  • Immunology and Allergy

Cite this

New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease. / Shores, Darla R; Binion, David G.; Freeman, Bruce A.; Baker, Paul R S.

In: Inflammatory Bowel Diseases, Vol. 17, No. 10, 10.2011, p. 2192-2204.

Research output: Contribution to journalArticle

Shores, Darla R ; Binion, David G. ; Freeman, Bruce A. ; Baker, Paul R S. / New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease. In: Inflammatory Bowel Diseases. 2011 ; Vol. 17, No. 10. pp. 2192-2204.
@article{7e21caf0c9ac475980e81464772a3f71,
title = "New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease",
abstract = "Dietary and endogenously modified lipids modulate inflammation by functioning as intra- and intercellular signaling molecules. Proinflammatory lipid mediators such as the eicosanoids compete against the signaling actions of newly discovered modified fatty acids that act to resolve inflammation. In inflammatory bowel disease, multiple aberrancies in lipid metabolism have been discovered, which shed further light on the pathogenesis of intestinal inflammation. Mechanisms by which lipids modulate inflammation, abnormalities of lipid metabolism in the setting of inflammatory bowel disease, and potential therapeutic application of lipid derivatives in this setting are discussed. (Inflamm Bowel Dis 2010)",
keywords = "fatty acids, inflammation, inflammatory bowel disease, metabolism, therapy",
author = "Shores, {Darla R} and Binion, {David G.} and Freeman, {Bruce A.} and Baker, {Paul R S}",
year = "2011",
month = "10",
doi = "10.1002/ibd.21560",
language = "English (US)",
volume = "17",
pages = "2192--2204",
journal = "Inflammatory Bowel Diseases",
issn = "1078-0998",
publisher = "John Wiley and Sons Inc.",
number = "10",

}

TY - JOUR

T1 - New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease

AU - Shores, Darla R

AU - Binion, David G.

AU - Freeman, Bruce A.

AU - Baker, Paul R S

PY - 2011/10

Y1 - 2011/10

N2 - Dietary and endogenously modified lipids modulate inflammation by functioning as intra- and intercellular signaling molecules. Proinflammatory lipid mediators such as the eicosanoids compete against the signaling actions of newly discovered modified fatty acids that act to resolve inflammation. In inflammatory bowel disease, multiple aberrancies in lipid metabolism have been discovered, which shed further light on the pathogenesis of intestinal inflammation. Mechanisms by which lipids modulate inflammation, abnormalities of lipid metabolism in the setting of inflammatory bowel disease, and potential therapeutic application of lipid derivatives in this setting are discussed. (Inflamm Bowel Dis 2010)

AB - Dietary and endogenously modified lipids modulate inflammation by functioning as intra- and intercellular signaling molecules. Proinflammatory lipid mediators such as the eicosanoids compete against the signaling actions of newly discovered modified fatty acids that act to resolve inflammation. In inflammatory bowel disease, multiple aberrancies in lipid metabolism have been discovered, which shed further light on the pathogenesis of intestinal inflammation. Mechanisms by which lipids modulate inflammation, abnormalities of lipid metabolism in the setting of inflammatory bowel disease, and potential therapeutic application of lipid derivatives in this setting are discussed. (Inflamm Bowel Dis 2010)

KW - fatty acids

KW - inflammation

KW - inflammatory bowel disease

KW - metabolism

KW - therapy

UR - http://www.scopus.com/inward/record.url?scp=80052729447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052729447&partnerID=8YFLogxK

U2 - 10.1002/ibd.21560

DO - 10.1002/ibd.21560

M3 - Article

VL - 17

SP - 2192

EP - 2204

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

SN - 1078-0998

IS - 10

ER -